2Indexed trials
drug · Product Intelligence
Allopurinol
Pipeline Intelligence
Allopurinol: 2 indexed trials, 2 sponsors; 0 linked Orange Book patents and 11 FDA-linked events where matched.
2Sponsors
0Orange Book patent links
11FDA-linked events
Development evidence
NCT03776656Assistance Publique - Hôpitaux de Paris · epilepsyPHASE2
NCT06276556Atom Therapeutics Co., Ltd · out_of_scopePHASE2, PHASE3
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALALLOPURINOL · 2025-06-13
FDA_APPROVALALLOPURINOL · 2023-12-14
FDA_APPROVALALLOPURINOL · 2023-08-03
FDA_APPROVALALLOPURINOL SODIUM · 2022-01-26
FDA_APPROVALALLOPURINOL · 2019-03-12
FDA_APPROVALALLOPURINOL · 2011-03-16
FDA_APPROVALALLOPURINOL SODIUM · 2004-08-26
FDA_APPROVALALLOPURINOL · 1987-01-09
FDA_APPROVALALLOPURINOL · 1986-10-24
FDA_APPROVALALLOPURINOL · 1984-11-16
FDA_APPROVALALLOPURINOL · 1984-09-28
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.